Advertisement

Skin Signs of Systemic Diseases

  • Adam BartlettEmail author
  • Pamela Palasanthiran
  • Marcia Hogeling
  • Orli Wargon
Chapter
  • 927 Downloads

Abstract

This chapter discusses examples of neutrophilic dermatoses and panniculitides, which represent a spectrum of non-infectious inflammatory conditions of the epidermis, dermis, and subcutaneous tissue. They can be associated with systemic diseases, including malignancies, and autoimmune and autoinflammatory disorders. Histopathological examination of the lesions is integral to the diagnosis of these cutaneous or subcutaneous inflammatory conditions. Treatment includes management of the associated systemic disease, in conjunction with a range of anti-inflammatory and immune-modulatory therapies.

Keywords

Neutrophilic dermatosis Sweet’s syndrome Pyoderma gangrenosum Panniculitis Cutaneous findings of systemic disease 

References

  1. 1.
    Prat L, Bouaziz JD, Wallach D, Vignon-Pennamen MD, Bagot M. Neutrophilic dermatoses as systemic diseases. Clin Dermatol. 2014;32(3):376–88.CrossRefPubMedGoogle Scholar
  2. 2.
    Saavedra AP, Kovacs SC, Moschella SL. Neutrophilic dermatoses. Clin Dermatol. 2006;24(6):470–81.CrossRefPubMedGoogle Scholar
  3. 3.
    Berk D, Bayliss SJ. Neutrophilic dermatoses in children. Pediatr Dermatol. 2008;25(5):509–19.CrossRefPubMedGoogle Scholar
  4. 4.
    Su WP, Liu HN. Diagnostic criteria for Sweet’s syndrome. Cutis. 1986;37(3):167–74.PubMedGoogle Scholar
  5. 5.
    Sutra-Loubet C, Carlotti A, Guillemette J, Wallach D. Neutrophilic panniculitis. J Am Acad Dermatol. 2004;50(2):280–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol. 2009;10(5):301–12.CrossRefPubMedGoogle Scholar
  7. 7.
    Webb K, Hlela C, Jordaan HF, Suliman S, Scriba T, Lipsker D, Scott C. A review and proposed approach to the neutrophilic dermatoses of childhood. Pediatr Dermatol. 2015;32(4):437–46.CrossRefPubMedGoogle Scholar
  8. 8.
    Cohen PR. Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Dabade TS, Davis MDP. Diagnosis and treatment of the neutrophilic dermatoses (pyoderma gangrenosum, Sweet’s syndrome). Dermatol Ther. 2011;24(2):273–84.CrossRefPubMedGoogle Scholar
  10. 10.
    Fazili TJ, Duncan D, Wanji L. Sweet’s syndrome. Am J Med. 2010;123(8):694–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Moraes AJP, Soares PMF, Zapata AL, Lotito APN, Sallum AME, Silva CAA. Panniculitis in childhood and adolescence. Pediatr Int. 2006;48(1):48–53.CrossRefPubMedGoogle Scholar
  12. 12.
    Torrelo A, Hernandez A. Panniculitis in children. Dermatol Clin. 2008;26(4):491–500.CrossRefPubMedGoogle Scholar
  13. 13.
    Delgado-Jimenez Y, Fraga J, Garcia-Diez A. Infective panniculitis. Dermatol Clin. 2008;26(4):471–80.CrossRefPubMedGoogle Scholar
  14. 14.
    Chan MP. Neutrophilic panniculitis: algorithmic approach to a heteregeneous group of disorders. Arch Pathol Lab Med. 2014;138(10):1337–43.CrossRefPubMedGoogle Scholar
  15. 15.
    Polcari IC, Stein SL. Panniculitis in childhood. Dermatol Ther. 2010;23(4):356–67.CrossRefPubMedGoogle Scholar
  16. 16.
    Diaz Cascajo C, Borghi S, Weyers W. Panniculitis: definition of terms and diagnostic strategy. Am J Dermatopathol. 2000;22(6):530–49.CrossRefPubMedGoogle Scholar
  17. 17.
    Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001;45(2):163–83.CrossRefPubMedGoogle Scholar
  18. 18.
    Requena LR, Yus ES. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001;45(3):325–61.CrossRefPubMedGoogle Scholar
  19. 19.
    Torrelo A, Patel S, Colmenero I, Gurbindo D, Lendinez F, Hernandez A, et al. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol. 2010;62(3):489–95.CrossRefPubMedGoogle Scholar
  20. 20.
    Powell FC, Su WPD, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermtol. 1996;34:395–409.CrossRefGoogle Scholar
  21. 21.
    Ormerod AD, Thomas KS, Craig FE, et al. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ. 2015;350:h2958. doi: 10.1136/bmj.h2958.Google Scholar
  22. 22.
    Nozawa T, Hara R, Kinoshita J, et al. Infliximab for a girl with refractory pyoderma gangrenosum. Nihon Rinsho Meneki Gakkai Kaishi. 2008;31:454–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Kaur MR, Lewis HM. Severe recalcitrant pyoderma gangrenosum treated with infliximab. Br J Dermatol. 2005;153:689–91.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Adam Bartlett
    • 1
    Email author
  • Pamela Palasanthiran
    • 1
  • Marcia Hogeling
    • 2
  • Orli Wargon
    • 3
  1. 1.Department of Immunology and Infectious DiseasesSydney Children’s HospitalRandwickAustralia
  2. 2.Division of DermatologyUniversity of California, Los AngelesLos AngelesUSA
  3. 3.Department Paediatric DermatologySydney Children’s HospitalRandwickAustralia

Personalised recommendations